INSM
INSM
NASDAQ · Biotechnology

Insmed Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$114.41
+5.65 (+5.19%)
As of Nov 7, 1:07 AM ET ·
Analyst Consensus
Strong Buy
31
Analysts
Very High
Coverage
Buy 30 97%
Hold 1 3%
Sell 0 0%
Price Target
Analyst Price Target +25.3% upside
Low Target $91.17
Average Target $143.40
High Target $177.14
Current Price $114.41
Current
$114.41
Target
$143.40
$91.17 $143.40 avg $177.14
Scenario Analysis
Bear Case
$91.17
-20.3%
Low target
Base Case
$143.40
+25.3%
Avg target
Bull Case
$177.14
+54.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$212.75
-46.2% from high
52-Week Low
$90.39
+26.6% from low
50-Day SMA
$111.21
+2.9% vs SMA
200-Day SMA
$124.15
-7.8% vs SMA
RSI (14)
71.4
Overbought
Target vs 52W High
$143.40
-32.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%